# FDA Inspection 1022105 - Navinta, LLC - August 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/navinta-llc/d7b6f6e5-255c-431f-99a7-3598a3c0f4ca
Source feed: FDA_Inspections

> FDA Inspection 1022105 for Navinta, LLC on August 18, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022105
- Company Name: Navinta, LLC
- Inspection Date: 2017-08-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252822 - 2024-09-30](https://www.keypedia.com/records/fda_inspections/navinta-llc/9e40121b-997f-407b-90ae-f59adae344e6)
- [FDA Inspection 1252822 - 2024-09-30](https://www.keypedia.com/records/fda_inspections/navinta-llc/753af808-56b4-46b6-8e11-20e16c9c2857)
- [FDA Inspection 1205480 - 2023-05-04](https://www.keypedia.com/records/fda_inspections/navinta-llc/191597f6-7722-47f9-ae0d-1d6a778c035b)
- [FDA Inspection 1084188 - 2019-03-28](https://www.keypedia.com/records/fda_inspections/navinta-llc/e5f0a259-43ef-4701-adfe-5b2f94d30760)
- [FDA Inspection 971010 - 2016-05-16](https://www.keypedia.com/records/fda_inspections/navinta-llc/00d89d55-9f1e-4732-b227-af5f6a4f6e36)

Company: https://www.keypedia.com/companies/navinta-llc/2049d986-174a-414f-812b-0f4347426e48

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c